InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Berkman Charles S, Vice-Président Senior, Conseiller Général et Secrétaire. Insider active across 3 companies, notably Ligand Pharmaceuticals INC. In total, 27 reports have been published. Breakdown: 0 buy · 2 sells. Total volume traded: €43k. History available since 26 January 2022. The latest transaction was filed on 7 April 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Berkman Charles S
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations27 total
7,157 shares@ US$1.498.6% of flowCommon StockSEC:0001628280-26-024131:1
13,542 shares0Common StockSEC:0001628280-26-024131:0
18,750 shares0Common StockSEC:0001392266-26-000002:0
13,542 shares0Common StockSEC:0001628280-26-008704:0
15,621 shares0Common StockSEC:0001392266-25-000006:0
13,542 shares0Common StockSEC:0001628280-25-016991:0
15,615 sharesCommon StockSEC:0001846253-25-000012:0
45,294 shares0Common StockSEC:0001846253-25-000006:0
15,621 sharesCommon StockSEC:0001846253-24-000099:0
366,511 sharesCommon StockSEC:0001846253-24-000012:0
6,954 shares@ US$5.2731.7% of flowCommon StockSEC:0002001011-24-000044:1
13,541 sharesCommon StockSEC:0002001011-24-000044:0
15,624 sharesCommon StockSEC:0002001011-24-000020:0
17,556 sharesCommon StockSEC:0002001011-24-000004:0
15,622 sharesCommon StockSEC:0002001011-23-000008:0
40,625 shares0Common StockSEC:0001846253-23-000041:0
1,973 shares@ US$3.806.6% of flowCommon StockSEC:0001846253-23-000016:0
46,864 shares0Common StockSEC:0000899243-23-001020:0
6,518 shares@ US$3.6621.1% of flowCommon StockSEC:0000899243-22-039582:0
10,580 shares@ US$3.3532.0% of flowCommon StockSEC:0000899243-22-037744:0
15,409 shares0Common StockSEC:0000899243-22-035045:0
353,716 sharesCommon StockSEC:0000899243-22-035063:0
11,944 sharesCommon StockSEC:0000899243-22-035038:0
5,375 shares0Common StockSEC:0000886163-22-000093:0
368 shares@ US$123.68100.0% of flowCommon StockSEC:0000886163-22-000024:0
25 of 27 declarations
About Berkman Charles S
Berkman Charles S is Senior Vice President, General Counsel and Secretary. He has 27 filings in total. In the sampled recent filings from 2016-02-16 to 2026-04-07, sales total 42859 EUR and the most frequent transaction nature is option exercise. His listed companies are OmniAb, Inc., Ligand Pharmaceuticals INC and OmniAb Operations, Inc.
